Method for treating neoplasia using humanized antibodies which bind to antigen A33
US6190640A · kind A · utility
16Cited by
3References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 19, 1996 |
| Grant date | Feb 20, 2001 |
| Priority date | — |
| Expiry date | Nov 19, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention involves the therapeutic use of humanized antibodies, fragments, etc., which bind to the antigen A33. These antibody molecules are useful in the treatment of various neoplasias, including colon cancer. Various modes of administration, and doses are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.